Taysha’s Extended Cash Runway and Transferred Rights
Taysha Extends Cash Runway Into 2026 and Transfers Rights
Hailshadow Taysha Gene Therapies (NASDAQ:TSHA) has made significant moves, transferring back the rights to three deprioritized programs while securing an extended cash runway into 2026 through a new loan and security agreement. The Texas-based gene therapy developer has returned the rights to TSHA-101 to Queen’s University and has similarly handed back the rights to TSHA-104 ...












